Related references
Note: Only part of the references are listed.Escherichia coli strains producing a novel Shiga toxin 2 subtype circulate in China
Xi Yang et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2020)
A genome-wide CRISPR/Cas9 screen reveals that the aryl hydrocarbon receptor stimulates sphingolipid levels
Saurav Majumder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
MT-5111: A novel HER2 targeting engineered toxin body in clinical development.
Roger J. Waltzman et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
PD-L1 targeted engineered toxin body provides direct cytotoxicity and T-cell mediated tumor targeting.
Roger J. Waltzman et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Structural and Functional Characterization of Stx2k, a New Subtype of Shiga Toxin 2
Anna C. Hughes et al.
MICROORGANISMS (2020)
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
Adrien Joseph et al.
TOXINS (2020)
RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
Ivan U. Kouzel et al.
SCIENTIFIC REPORTS (2020)
Molecular Biology ofEscherichia coliShiga Toxins' Effects on Mammalian Cells
Christian Menge
TOXINS (2020)
Verotoxin Receptor-Based Pathology and Therapies
Clifford Lingwood
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor
Karl Johansson et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Pooled Screens Identify GPR108 and TM9SF2 as Host Cell Factors Critical for AAV Transduction
W. Hans Meisen et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets
Robyn A. A. Oldham et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS
Morena S. Havira et al.
SCIENCE IMMUNOLOGY (2020)
Shiga-Toxin E. coli Hemolytic Uremic Syndrome: Review of Management and Long-term Outcome
V. J. Harkins et al.
CURRENT PEDIATRICS REPORTS (2020)
Tissue Responses to Shiga Toxin in Human Intestinel Organoids
Suman Pradhan et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Targeted Protein Degradation through Cytosolic Delivery of Monobody Binders Using Bacterial Toxins
Nadine Eliane Schmit et al.
ACS CHEMICAL BIOLOGY (2019)
A Genome-Wide Haploid Genetic Screen Identifies Heparan Sulfate-Associated Genes and the Macropinocytosis Modulator TMED10 as Factors Supporting Vaccinia Virus Infection
Rutger D. Luteijn et al.
JOURNAL OF VIROLOGY (2019)
Recombinant HcpA-EspA-Tir-Stx2B chimeric protein induces immunity against attachment and toxicity of Escherichia coli O157:H7
Emad Kordbacheh et al.
MICROBIAL PATHOGENESIS (2019)
Roles of Shiga Toxins in Immunopathology
Moo-Seung Lee et al.
TOXINS (2019)
Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells
Liang Tao et al.
NATURE MICROBIOLOGY (2019)
A Phase 2 Study of MT-3724 to Evaluate Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Daniel O. Persky et al.
BLOOD (2019)
A Phase 1 First-in-Human Study of the Anti-CD38 Dimeric Fusion Protein TAK-169 for the Treatment of Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) Who Are Proteasome Inhibitor (PI)- and Immunomodulatory Drug ( IMiD)-Refractory, Including Pts Relapsed/Refractory (R/R) or Naive to Daratumumab (dara)
Shaji K. Kumar et al.
BLOOD (2019)
A CRISPR Screen Identifies LAPTM4A and TM9SF Proteins as Glycolipid-Regulating Factors
Toshiyuki Yamaji et al.
ISCIENCE (2019)
Combination of CD20 targeted engineered toxin body, MT-3724, with chemotherapy or IMiDs for the treatment of non Hodgkin's lymphoma
Jack P. Higgins et al.
CANCER RESEARCH (2019)
Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy
Vera Luginbuehl et al.
BIOTECHNOLOGY ADVANCES (2018)
Engineering and cytosolic delivery of a native regulatory protein and its variants for modulation of ERK2 signaling pathway
Jeong-Hyun Ryou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2018)
Overview of the role of Shiga toxins in porcine edema disease pathogenesis
Natalia A. Casanova et al.
TOXICON (2018)
CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection
Alline R. Pacheco et al.
MBIO (2018)
Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype
Xiangning Bai et al.
SCIENTIFIC REPORTS (2018)
Safety and efficacy of anti-CD20 immunotoxin MT-3724 in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) in a phase I study.
Michelle A. Fanale et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genome-wide CRISPR screens for Shiga toxins and ricin reveal Golgi proteins critical for glycosylation
Songhai Tian et al.
PLOS BIOLOGY (2018)
Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene
Christopher R. Clark et al.
SCIENTIFIC REPORTS (2018)
Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome
Yu-Jin Jeong et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection
Atsushi Tanaka et al.
JOURNAL OF VIROLOGY (2017)
TMEM165 deficiencies in Congenital Disorders of Glycosylation type II(CDG-II): Clues and evidences for roles of the protein in Golgi functions and ion homeostasis
Eudoxie Dulary et al.
TISSUE & CELL (2017)
Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome
Jan Beneke et al.
TRANSFUSION MEDICINE REVIEWS (2017)
Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines
Ivan U. Kouzel et al.
TOXINS (2017)
Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli
Sayali S. Karve et al.
PLOS ONE (2017)
Shiga Toxins Activate the NLRP3 Inflammasome Pathway To Promote Both Production of the Proinflammatory Cytokine Interleukin-1 beta and Apoptotic Cell Death
Moo-Seung Lee et al.
INFECTION AND IMMUNITY (2016)
Engineering of Bacterial Exotoxins for Highly Efficient and Receptor-Specific Intracellular Delivery of Diverse Cargos
Jeong-Hyun Ryou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2016)
Glycosylation abnormalities in Gdt1p/TMEM165 deficient cells result from a defect in Golgi manganese homeostasis
Sven Potelle et al.
HUMAN MOLECULAR GENETICS (2016)
Use of the Escherichia coli Identification Microarray for Characterizing the Health Risks of Shiga Toxin-Producing Escherichia coli Isolated from Foods
David W. Lacher et al.
JOURNAL OF FOOD PROTECTION (2016)
Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit
Philipp Emanuel Geyer et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Shiga-like toxin-based high-efficiency and receptor-specific intracellular delivery system for a protein
Jeong-Hyun Ryou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Targeted Shiga toxin-drug conjugates prepared via Cu-free click chemistry
Vesela Kostova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
A new delivery system for auristatin in STxB-drug conjugate therapy
Cornelie Batisse et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Shiga Toxin-Induced Complement-Mediated Hemolysis and Release of Complement-Coated Red Blood Cell-Derived Microvesicles in Hemolytic Uremic Syndrome
Ida Arvidsson et al.
JOURNAL OF IMMUNOLOGY (2015)
A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles
Anne-Lie Stahl et al.
PLOS PATHOGENS (2015)
The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells
Jeremy R. Brandelli et al.
TOXINS (2015)
Sphingolipid Metabolism and Interorganellar Transport: Localization of Sphingolipid Enzymes and Lipid Transfer Proteins
Toshiyuki Yamaji et al.
TRAFFIC (2015)
Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
Lev Stimmer et al.
BMC CANCER (2014)
Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA
R. E. Luna-Gierke et al.
EPIDEMIOLOGY AND INFECTION (2014)
An in vivo model of human small intestine using pluripotent stem cells
Carey L. Watson et al.
NATURE MEDICINE (2014)
Isolation and Characteristics of Shiga Toxin 2f-Producing Escherichia coli among Pigeons in Kyushu, Japan
Koichi Murakami et al.
PLOS ONE (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Shiga Toxin (Stx) Classification, Structure, and Function
Angela R. Melton-Celsa
MICROBIOLOGY SPECTRUM (2014)
Distinct Renal Pathology and a Chemotactic Phenotype after Enterohemorrhagic Escherichia coli Shiga Toxins in Non-Human Primate Models of Hemolytic Uremic Syndrome
Deborah J. Stearns-Kurosawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Retrograde transport of protein toxins through the Golgi apparatus
Kirsten Sandvig et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2013)
Shiga Toxin 2 Reduces Complement Inhibitor CD59 Expression on Human Renal Tubular Epithelial and Glomerular Endothelial Cells
Silvia Ehrlenbach et al.
INFECTION AND IMMUNITY (2013)
Action of Shiga Toxin Type-2 and Subtilase Cytotoxin on Human Microvascular Endothelial Cells
Maria M. Amaral et al.
PLOS ONE (2013)
Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry
Lucas T. Jae et al.
SCIENCE (2013)
Immunotoxins: The Role of the Toxin
Antonella Antignani et al.
TOXINS (2013)
TMEM165 Deficiency Causes a Congenital Disorder of Glycosylation
Francois Foulquier et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Synthetic Nanocarriers for Intracellular Protein Delivery
Juanjuan Du et al.
CURRENT DRUG METABOLISM (2012)
Clinical utility of three-dimensional contrast-enhanced ultrasound in the differentiation between noninvasive and invasive neoplasms of urinary bladder
Qiu-yang Li et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
A novel murine infection model for Shiga toxin-producing Escherichia coli
Emily M. Mallick et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature
Flemming Scheutz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP-protein cargos to the cytosol of eukaryotic cells
Arshiya F. Mohammed et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis
Somshuvra Mukhopadhyay et al.
SCIENCE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies
Lindsay S. Keir et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2012)
Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib
Samuel M. Stone et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies
Alline R. Pacheco et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)
Accuracy of contrast-enhanced ultrasound in the detection of bladder cancer
C. Nicolau et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Shiga Toxin Subtypes Display Dramatic Differences in Potency
Cynthia A. Fuller et al.
INFECTION AND IMMUNITY (2011)
Mouse Models of Escherichia coli O157:H7 Infection and Shiga Toxin Injection
Krystle L. Mohawk et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit
Matthias Maak et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Epidemic Profile of Shiga-Toxin-Producing Escherichia coli O104:H4 Outbreak in Germany
Christina Frank et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins
Ruth Milkereit et al.
PLOS ONE (2011)
A Glucosylceramide Synthase Inhibitor Protects Rats Against the Cytotoxic Effects of Shiga Toxin 2
Claudia Silberstein et al.
PEDIATRIC RESEARCH (2011)
Tumor Delivery of Ultrasound Contrast Agents Using Shiga Toxin B Subunit
Olivier Couture et al.
MOLECULAR IMAGING (2011)
Shiga toxin and its use in targeted cancer therapy and imaging
Nikolai Engedal et al.
MICROBIAL BIOTECHNOLOGY (2011)
Actin Dynamics Drive Membrane Reorganization and Scission in Clathrin-Independent Endocytosis
Winfried Roemer et al.
CELL (2010)
New aspects of the regulation of glycosphingolipid receptor function
Clifford A. Lingwood et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2010)
Globotriaosyl ceramide receptor function - Where membrane structure and pathology intersect
C. A. Lingwood et al.
FEBS LETTERS (2010)
Top-Down Proteomic Identification of Furin-Cleaved alpha-Subunit of Shiga Toxin 2 from Escherichia coli O157:H7 Using MALDI-TOF-TOF-MS/MS
Clifton K. Fagerquist et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Shiga toxins - from cell biology to biomedical applications
Ludger Johannes et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease
Tom G. Obrig
TOXINS (2010)
Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis
David Johansson et al.
BMC CANCER (2009)
Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice
D. Paixao-Cavalcante et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Isolation of atypical enteropathogenic Escherichia coli and Shiga toxin 1 and 2f-producing Escherichia coli from avian species in India
S. Farooq et al.
LETTERS IN APPLIED MICROBIOLOGY (2009)
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
Marina Noris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Tracing the Retrograde Route in Protein Trafficking
Ludger Johannes et al.
CELL (2008)
Synthesis and Properties of a Mitochondrial Peripheral Benzodiazepine Receptor Conjugate
Abdessamad El Alaoui et al.
CHEMMEDCHEM (2008)
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice
Kathryn A. Eaton et al.
INFECTION AND IMMUNITY (2008)
TM9SF4 is required for Drosophila cellular immunity via cell adhesion and phagocytosis
Evelyne Bergeret et al.
JOURNAL OF CELL SCIENCE (2008)
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons
Fumiko Obata et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool
Thomas Falguieres et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits
Alexis Garcia et al.
MICROBES AND INFECTION (2008)
Development of an experimental hemolytic uremic syndrome in rats
Elsa Zotta et al.
PEDIATRIC NEPHROLOGY (2008)
In Vivo Tumor Targeting by the B-Subunit of Shiga Toxin
Thomas Viel et al.
MOLECULAR IMAGING (2008)
Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug
Abdessamad El Alaoui et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease
Tiffany R. Keepers et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity
Benoit Vingert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Renal injury is a consistent finding in Dutch belted rabbits experimentally infected with enterohemorrhagic Escherichia coli
A García et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to vVerotoxins
T Okuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Shiga-like toxin subunit B (SLTB)-enhanced delivery of chlorin e6 (Ce6) improves cell killing
MT Tarragó-Trani et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2006)
The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer
O Kovbasnjuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Oral immunization with a shiga toxin B subunit::rotavirus NSP490 fusion protein protects mice against gastroenteritis
NW Choi et al.
VACCINE (2005)
Hemolytic uremic syndrome
M Noris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
PI Tarr et al.
LANCET (2005)
Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes
A Saint-Pol et al.
DEVELOPMENTAL CELL (2004)
Shiga toxin binds to activated platelets
SA Ghosh et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7
ME Fraser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization
N Haicheur et al.
INTERNATIONAL IMMUNOLOGY (2003)
Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells
A Matussek et al.
BLOOD (2003)
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome
RL Siegler et al.
PEDIATRIC NEPHROLOGY (2003)
Acute kidney failure - A pediatric experience over 20 years
DM Williams et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2002)
Lysosome-associated protein transmembrane 4α (LAPTM4α) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes
DL Hogue et al.
BIOCHEMICAL JOURNAL (2002)
The treatment of malignant meningioma with verotoxin
B Salhia et al.
NEOPLASIA (2002)
Urinary concentrating defect in rats given Shiga toxin: elevation in urinary AQP2 level associated with polyuria
J Sugatani et al.
LIFE SCIENCES (2002)
Expression of the Gb3/CD77 synthase gene in megakaryoblastic leukemia cells - Implication in the sensitivity to verotoxins
K Furukawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Escherichia coli harboring shiga toxin 2 gene variants: frequency and association with clinical symptoms
AW Friedrich et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Kinetic analysis of binding between shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance
H Nakajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A monkey model for enterohemorrhagic Escherichia coli infection
G Kang et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS?
RS Heyderman et al.
TRENDS IN MICROBIOLOGY (2001)
Phg1p is a nine-transmembrane protein superfamily member involved in Dictyostelium adhesion and phagocytosis
S Cornillon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The B subunit of shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
N Haicheur et al.
JOURNAL OF IMMUNOLOGY (2000)
Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of α1,4-glycosyltransferases conserved in plants, insects, and mammals
JJ Keusch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids
Y Kojima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons
H Schmidt et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
